JP MORGAN/CALL/QIAGEN/60/0.1/19.12.25 Share Price

Warrant

DE000JK5U492

Market Closed - Börse Stuttgart 01:25:05 31/05/2024 pm IST
0.099 EUR -1.00% Intraday chart for JP MORGAN/CALL/QIAGEN/60/0.1/19.12.25
1 month-23.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/24/31 0.099 -1.00%
30/24/30 0.1 -.--%
29/24/29 0.1 -16.67%
28/24/28 0.12 -.--%
27/24/27 0.12 -.--%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 01:25 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying QIAGEN N.V.
Issuer J.P. Morgan
WKN JK5U49
ISINDE000JK5U492
Date issued 14/03/2024
Strike 60
Maturity 19/12/2025 (565 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.18
Lowest since issue 0.084
Delta0.2x
Omega 5.735
Premium55.96x
Gearing28.12x
Moneyness 0.6562
Difference Strike 20.63
Difference Strike %+34.38%
Spread 0.06
Spread %35.29%
Theoretical value 0.1400
Implied Volatility 29.36 %
Total Loss Probability 88.37 %
Intrinsic value 0.000000
Present value 0.1400
Break even 61.40 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.26 USD
Average target price
50.14 USD
Spread / Average Target
+15.90%
Consensus